Evaluation of different microtiter plate-based methods for the quantitative assessment of Staphylococcus aureus biofilms
Abstract
ABSTRACT:
Aim: To quantitatively assess Staphylococcus aureus biofilms. Materials & methods: In addition to the qualitative Congo red agar (CRA) method, we used the bioluminescence (BLM), safranine (SAF), crystal violet (CRV) and resazurin (RES) high-throughput microtiter plate-based quantitative assays. Results: 60.47% (26/43) of S. aureus clinical isolates were weak biofilm producers. The CRA method detected positive-slime phenotypes (13.95%), but was unable to distinguish weak from negative producers. BLM assays demonstrated significant correlations with RES (highest), CRV and SAF (lowest). Lower coefficient of variation values indicate precision. BLM scored highest precision (coefficient of variation = 0.013) followed by RES, SAF and CRV. Conclusion: BLM and RES detect live biomass in S. aureus biofilms (for physiological studies). SAF and CRV detect live/dead bacteria plus biofilm matrix (for monitoring overall biofilm architecture, not only its cell viability). Reliable assays are essential for effective biofilm therapy.
Papers of special note have been highlighted as: •• of considerable interest
References
- 1 . To build a biofilm. J. Bacteriol. 185(9), 2687–2689 (2003).
- 2 . Biofilms as complex differentiated communities. Annu. Rev. Microbiol. 56, 187–209 (2002).
- 3 . Bacterial adhesion: seen any good biofilms lately? Clin. Microbiol. Rev. 15(2), 155–166 (2002).
- 4 . Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15(2), 167–193 (2002).
- 5 . Bacterial biofilms: an emerging link to disease pathogenesis. Annu. Rev. Microbiol. 57, 677–701 (2003).
- 6 . Staphylococcus epidermidis – the ‘accidental’ pathogen. Nat. Rev. Micro. 7(8), 555–567 (2009).
- 7 . Staphylococcus epidermidis device-related infections: pathogenesis and clinical management. J. Pharm. Pharmacol. 60(12), 1551–1571 (2008).
- 8 . Prevention and treatment of Staphylococcus biofilms. Curr. Med. Chem. 15(30), 3185–3195 (2008).
- 9 . Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Ag. 35(4), 322–332 (2010).
- 10 . Bacterial biofilms within the clinical setting: what healthcare professionals should know. J. Hosp. Infect. 64(4), 313–325 (2006).
- 11 . Epidemiology of methicillin-resistant staphylococci in Europe. Clin. Microbiol. Infect. 9(12), 1179–1186 (2003).
- 12 European surveillance of ICU-acquired infections (HELICS-ICU): methods and main results. J. Hosp. Infect. 65(Suppl. 2), 171–173 (2007).
- 13 . A combination of assays reveals biomass differences in biofilms formed by Escherichia coli mutants. Lett. Appl. Microbiol. 49(3), 299–304 (2009).•• The authors could develop an assay system that could quantify bioburden in the biofilms.
- 14 . Biofilm formation and the presence of the intercellular adhesion locus ica among staphylococci from food and food processing environments. Appl. Environ. Microbiol. 69(9), 5648–5655 (2003).•• Provides a quantitative and discriminatory scale for categorization of Staphylococcus aureus biofilm formation into strong, weak and negative.
- 15 . Combinatorial materials research applied to the development of new surface coatings III. Utilisation of a high-throughput multiwell plate screening method to rapidly assess bacterial biofilm retention on antifouling surfaces. Biofouling 23(1–2), 37–44 (2007).
- 16 . A new colorimetric microtitre model for the detection of Staphylococcus aureus biofilms. Lett. Appl. Microbiol. 46(2), 249–254 (2008).•• Established simple and reproducible resazurin-based microplate assay.
- 17 . Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections. J. Clin. Microbiol. 39(6), 2151–2156 (2001).•• Utilized Congo red agar for clustering staphylococcal isolates based on their slime production.
- 18 . Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9(1), 34–39 (2001).
- 19 . A simple method to measure cell viability in proliferation and cytotoxicity assays. Braz. Oral Res. 23(3), 255–262 (2009).
- 20 . Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 267(17), 5421–5426 (2000).
- 21 Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob. Agents Chemother. 49(7), 2612–2617 (2005).
- 22 . Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth, and its application in the in vitro antibacterial screening of phytochemicals. Methods 42(4), 321–324 (2007).
- 23 . Optimization of resazurin-based viability staining for quantification of microbial biofilms. J. Microbiol. Methods 98, 31–34 (2014).•• Addressed optimized resazurin-based viability assay for microbial biofilms.
- 24 . Anaerobic gene expression in Staphylococcus aureus. J. Bacteriol. 189(11), 4275–4289 (2007).
- 25 . Uses and limitations of the XTT assay in studies of Candida growth and metabolism. J. Clin. Microbiol. 41(1), 506–508 (2003).
- 26 . New method for detecting slime production by coagulase negative staphylococci. J. Clin. Pathol. 42(8), 872–874 (1989).
- 27 The phenotypic and genetic biofilm formation characteristics of coagulase-negative staphylococci isolates in children with otitis media. Int. J. Pediatr. Otorhi. 75(1), 126–130 (2011).
- 28 . Evaluation of different detection methods of biofilm formation in Staphylococcus aureus. Med. Microbiol. Immunol. 191(2), 101–106 (2002).
- 29 . Detection of biofilm formation among the clinical isolates of staphylococci: an evaluation of three different screening methods. Indian J. Med. Microbiol. 24(1), 25–29 (2006).
- 30 . Detection of slime production by means of an optimised Congo red agar plate test based on a colourimetric scale in Staphylococcus epidermidis clinical isolates genotyped for ica locus. Biomaterials 23(21), 4233–4239 (2002).•• Correlated Congo red agar plate with the existence of icaA and icaD genes.
- 31 . A microtiter plate assay for Staphylococcus aureus biofilm quantification at various pH levels and hydrogen peroxide supplementation. New Microbiol. 33(2), 137–145 (2010).•• Assessed the effect of pH as a stress factor that influences production of biofilm in Staphylococcus aureus isolates.
- 32 . Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis. J. Antimicrob. Chemother. 48(6), 793–801 (2001).•• Employed ATP bioluminescence for viable bacterial cell quantification in Staphylococcus epidermidis biofilms.
- 33 . High-throughput screens for small-molecule inhibitors of Pseudomonas aeruginosa biofilm development. Antimicrob. Agents Chemother. 51(10), 3582–3590 (2007).
- 34 . Susceptibility of Actinobacillus actinomycetemcomitans to six antibiotics decreases as biofilm matures. J. Antimicrob. Chemother. 59(1), 59–65 (2007).
- 35 . Rapid methods to assess sanitizing efficacy of benzalkonium chloride to Listeria monocytogenes biofilms. J. Microbiol. Methods 71(3), 231–237 (2007).
- 36 Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J. Clin. Microbiol. 22(6), 996–1006 (1985).